Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Floyd

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
European Cardiology|March 18, 2020
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 GuidelinesChristopher N Floyd
Aviation, Space, and Environmental Medicine|September 1, 1980
The importance of ammonia in the metabolic effects of hydrazineW N Floyd
Southern Medical Journal|April 1, 1979
Traumatic hemobilia: coordination of roentgenographic, scintigraphic, and angiographic findingsW N Floyd
Clinical Medicine (London, England)|February 3, 2016
Hypertension - state of the art 2015Christopher N Floyd
British Journal of Clinical Pharmacology|July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysisChristopher N Floyd, Albert Ferro
JRSM Cardiovascular Disease|November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuaryChristopher N Floyd, Albert Ferro
Southern Medical Journal|February 1, 1985
Cholangiography and bile cytopathology in the diagnosis of biliary tract obstructionW N Floyd, C Cobb
Pharmacology & Therapeutics|September 3, 2013
Mechanisms of aspirin resistanceChristopher N Floyd, Albert Ferro
Prostaglandins & Other Lipid Mediators|April 15, 2015
Antiplatelet drug resistance: Molecular insights and clinical implicationsChristopher N Floyd, Albert Ferro
Current Opinion in Cardiology|May 14, 2020
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?Christopher N Floyd, Anthony S Wierzbicki
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
European Cardiology|March 18, 2020
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 GuidelinesChristopher N Floyd
Aviation, Space, and Environmental Medicine|September 1, 1980
The importance of ammonia in the metabolic effects of hydrazineW N Floyd
Southern Medical Journal|April 1, 1979
Traumatic hemobilia: coordination of roentgenographic, scintigraphic, and angiographic findingsW N Floyd
Clinical Medicine (London, England)|February 3, 2016
Hypertension - state of the art 2015Christopher N Floyd
British Journal of Clinical Pharmacology|July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysisChristopher N Floyd, Albert Ferro
JRSM Cardiovascular Disease|November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuaryChristopher N Floyd, Albert Ferro
Southern Medical Journal|February 1, 1985
Cholangiography and bile cytopathology in the diagnosis of biliary tract obstructionW N Floyd, C Cobb
Pharmacology & Therapeutics|September 3, 2013
Mechanisms of aspirin resistanceChristopher N Floyd, Albert Ferro
Prostaglandins & Other Lipid Mediators|April 15, 2015
Antiplatelet drug resistance: Molecular insights and clinical implicationsChristopher N Floyd, Albert Ferro
Current Opinion in Cardiology|May 14, 2020
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?Christopher N Floyd, Anthony S Wierzbicki
Pageof 7